Patents by Inventor Eun Kyoung Shin

Eun Kyoung Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PRODUCING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE
    Publication number: 20230416683
    Abstract: The present invention relates to: a method in which extracellular vesicles with improved therapeutic efficacy are produced from a three-dimensional spheroid-type cell aggregate produced using a microwell having a particular structure; and extracellular vesicles produced by the production method. When the method for producing extracellular vesicles, according to the present invention, is used, extracellular vesicles having enhanced efficacy can be mass-produced, and the produced extracellular vesicles include higher levels of various efficiency factors than existing extracellular vesicles and exhibit uniform characteristics without difference between donors, and thus can be used for various purposes in the medical industry.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 28, 2023
    Inventors: Eun Hee Kim, Eun Kyoung Shin, Ji Hee Sung
  • Method for producing stem cell-derived extracellular vesicle
    Patent number: 11643638
    Abstract: Provided are a method for producing stem cell-derived extracellular vesicles by using a three-dimensional cell culture process, use of three-dimensional cell aggregates of stem cells in producing extracellular vesicles, a culture of three-dimensional cell aggregates of stem cells comprising a high concentration of extracellular vesicles, and a pharmaceutical composition comprising the culture.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: May 9, 2023
    Assignees: Samsung Electronics Co., Ltd., S & E Bio Corporation
    Inventors: Jae Min Cha, Oh Young Bang, Gyeong Joon Moon, Eun Kyoung Shin
  • METHOD FOR PRODUCING STEM CELL-DERIVED EXTRACELLULAR VESICLE
    Publication number: 20190144830
    Abstract: Provided are a method for producing stem cell-derived extracellular vesicles by using a three-dimensional cell culture process, use of three-dimensional cell aggregates of stem cells in producing extracellular vesicles, a culture of three-dimensional cell aggregates of stem cells comprising a high concentration of extracellular vesicles, and a pharmaceutical composition comprising the culture.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 16, 2019
    Inventors: Jae Min CHA, Oh Young BANG, Gyeong Joon MOON, Eun Kyoung SHIN
  • Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis
    Patent number: 10058558
    Abstract: The present invention provides a novel use of N1-cyclic amine-N5-substituted biguanide derivatives for preparing a medicine for preventing or treating fibrosis. The N1-cyclic amine-N5-substituted biguanide derivatives according to the present invention are capable of effectively inhibiting fibrosis by effectively suppressing the EMT.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: August 28, 2018
    Assignee: ImmunoMet Therapeutics Inc.
    Inventors: Sung Wuk Kim, Soon Im Lee, Yeon Jung Song, Min Jae Shin, Kook Hwan Oh, Kyung Don Ju, Eun Kyoung Shin, Ji Sun Lee, Hye Jin Heo, Hong Bum Lee, Ji Ae Kook, Min Jeong Kim, Hye Soun Eum
  • PHARMACEUTICAL COMPOSITION COMPRISING N1-CYCLIC AMINE-N5-SUBSTITUTED BIGUANIDE DERIVATIVES AS AN INGREDIENT FOR PREVENTING OR TREATING FIBROSIS
    Publication number: 20160101112
    Abstract: The present invention provides a novel use of N1-cyclic amine-N5-substituted biguanide derivatives for preparing a medicine for preventing or treating fibrosis. The N1-cyclic amine-N5-substituted biguanide derivatives according to the present invention are capable of effectively inhibiting fibrosis by effectively suppressing the EMT.
    Type: Application
    Filed: May 20, 2014
    Publication date: April 14, 2016
    Applicant: IMMUNOMET THERAPEUTICS INC
    Inventors: Sung Wuk Kim, Soon Im Lee, Yeon Jung Song, Min Jae Shin, Kook Hwan Oh, Kyung Don Ju, Eun Kyoung Shin, Ji Sun Lee, Hye Jin Heo, Hong Bum Lee, Ji Ae Kook, Min Jeong Kim, Hye Soun Eum